The Role of Cell Blocks and Immunohistochemistry in Thyroid Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Bethesda Category

被引:7
作者
Abram, Mikk [1 ,2 ]
Huhtamella, Roope [1 ,3 ]
Kalfert, David [4 ]
Hakso-Makinen, Heli [3 ]
Ludvikova, Marie [5 ]
Kholova, Ivana [1 ,3 ]
机构
[1] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland
[2] North Estonia Med Ctr Fdn, Tallinn, Estonia
[3] Fimlab Labs, Dept Pathol, Arvo Ylpon Katu 4, FI-33520 Tampere, Finland
[4] Charles Univ Prague, Fac Med 1, Univ Hosp Motol, Dept Otorhinolaryngol & Head & Neck Surg, Prague, Czech Republic
[5] Charles Univ Prague, Fac Med Pilsen, Dept Biol, Plzen, Czech Republic
关键词
Thyroid gland; Cell block; Galectin-3; Cytokeratin; 19; HBME-1;
D O I
10.1159/000514906
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction: Thyroid cytology is a widely accepted tool in the clinical triaging of nodular lesions. Cell blocks (CBs) can help in the diagnosis of atypical lesions, namely, thyroid Bethesda category of Atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS). Methods: In a series of 224 AUS/FLUS thyroid samples with CB, we studied CB cellularity and feasibility of 3 immunohistochemical markers (cytokeratin 19 [CK19], HBME-1, and galectin-3) apart and in combination. Results: The CBs were non-diagnostic in 34 cases. Twenty-four CBs contained <10 cells, 45 CBs 10-50 cells, and 121 CBs >50 cells. Notably, more cellularity was found in CBs performed by plasma-thrombin and in-house techniques (p < 0.001). The diagnostic accuracy to detect malignancy was 65.1% for CK19, 72.1% for HBME-1, and 70.3% for galectin-3. Conclusion: In conclusion, CB cellularity is essential for successful immunohistochemistry application and further diagnostic workup of AUS/FLUS cases.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 38 条
  • [31] Preanalytic specimen triage: Smears, cell blocks, cytospin preparations, transport media, and cytobanking
    Santos, Gilda da Cunha
    Saieg, Mauro A.
    [J]. CANCER CYTOPATHOLOGY, 2017, 125 : 455 - 464
  • [33] Validation of immunohistochemical tests performed on cytology cell block material: Practical application of the College of American Pathologists' guidelines
    Satturwar, Swati
    Malenie, Renuka
    Sutton, Ann
    Dai, Ding
    Aly, F. Zahra
    [J]. CYTOJOURNAL, 2019, 16
  • [34] CellBlockistry: Chemistry and art of cell-block making - A detailed review of various historical options with recent advances
    Shidham, Vinod B.
    [J]. CYTOJOURNAL, 2019, 16
  • [35] Immunocytochemistry practices in European cytopathology laboratories-Review of European Federation of Cytology Societies (EFCS) online survey results with best practice recommendations
    Srebotnik Kirbis, Irena
    Rodrigues Roque, Ruben
    Bongiovanni, Massimo
    Strojan Flezar, Margareta
    Cochand-Priollet, Beatrix
    [J]. CANCER CYTOPATHOLOGY, 2020, 128 (10) : 757 - 766
  • [36] A meta-analytic review of the Bethesda System for Reporting Thyroid Cytopathology: Has the rate of malignancy in indeterminate lesions been underestimated?
    Straccia, Patrizia
    Rossi, Esther Diana
    Bizzarro, Tommaso
    Brunelli, Chiara
    Cianfrini, Federica
    Damiani, Domenico
    Fadda, Guido
    [J]. CANCER CYTOPATHOLOGY, 2015, 123 (12) : 713 - 722
  • [37] Clinical Outcome for Atypia of Undetermined Significance in Thyroid Fine-Needle Aspirations Should Repeated FNA Be the Preferred Initial Approach?
    VanderLaan, Paul A.
    Marqusee, Ellen
    Krane, Jeffrey F.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (05) : 770 - 775
  • [38] Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis
    Vuong, Huy Gia
    Ngo, Hanh Thi Tuyet
    Bychkov, Andrey
    Jung, Chan Kwon
    Vu, Trang Huyen
    Lu, Kim Bach
    Kakudo, Kennichi
    Kondo, Tetsuo
    [J]. CANCER CYTOPATHOLOGY, 2020, 128 (04) : 238 - 249